Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?
Agios Pharmaceuticals Ownership Summary
Agios Pharmaceuticals is owned by 59.29% institutional investors, 1.73% insiders, and 38.98% retail investors. Farallon capital management is the largest institutional shareholder, holding 9.98% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.16% of its assets in Agios Pharmaceuticals shares.
AGIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Agios Pharmaceuticals | 59.29% | 1.73% | 38.98% |
| Sector | Healthcare Stocks | 232.52% | 10.72% | -143.24% |
| Industry | Biotech Stocks | 384.56% | 10.59% | -295.14% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 5.78M | 9.98% | $232.05M |
| Vanguard group | 5.59M | 9.62% | $152.28M |
| Blackrock funding, inc. /de | 5.24M | 9.01% | $142.51M |
| Blackrock | 4.86M | 8.55% | $209.52M |
| Bellevue group | 3.71M | 6.41% | $149.11M |
| Erste asset management gmbh | 2.80M | 4.82% | $76.34M |
| Paradigm biocapital advisors lp | 2.67M | 4.61% | $107.32M |
| Wellington management group llp | 2.47M | 4.27% | $99.20M |
| Commodore capital lp | 2.34M | 4.04% | $93.86M |
| State street | 2.26M | 3.91% | $90.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 1.13M | 5.95% | $45.41M |
| Commodore capital lp | 2.34M | 4.58% | $93.86M |
| Cutter capital management, lp | 301.62K | 4.06% | $9.91M |
| Bellevue group | 3.71M | 3.10% | $149.11M |
| Paradigm biocapital advisors lp | 2.67M | 3.05% | $107.32M |
| Tcg crossover management | 1.43M | 2.82% | $57.40M |
| Rock springs capital management lp | 958.54K | 2.25% | $38.48M |
| Palo alto investors lp | 265.50K | 1.97% | $10.66M |
| Highvista strategies | 195.30K | 1.92% | $7.84M |
| Frazier life sciences management | 1.28M | 1.54% | $51.37M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 2.47M | 0.02% | 2.05M |
| Paradigm biocapital advisors lp | 2.67M | 3.05% | 1.53M |
| Tcg crossover management | 1.43M | 2.82% | 733.04K |
| Jane street group | 1.12M | 0.00% | 725.93K |
| Capital investors | 703.87K | 0.00% | 703.87K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Macquarie group | - | - | -1.96M |
| Jefferies financial group | - | - | -1.50M |
| Bvf inc/il | - | - | -1.07M |
| Polar capital | - | - | -1.00M |
| T. rowe price investment management | - | - | -928.60K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Capital investors | 703.87K | 0.00% | 703.87K | $19.16M |
| Axa investment managers | 177.68K | 0.02% | 177.68K | $7.13M |
| Group one trading | 166.61K | 0.01% | 166.61K | $4.54M |
| Hrt financial lp | 146.47K | 0.01% | 146.47K | $3.99M |
| Norges bank | 145.09K | 0.00% | 145.09K | $4.77M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Dinuzzo private wealth | -1.00 |
| Global financial private client | -3.00 |
| Riggs asset managment | -3.00 |
| Hfm investment advisors | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 165 | -31.82% | 34,473,117 | -45.71% | 59 | 0.49% | 89 | -24.58% | 49 | -28.99% |
| Sep 30, 2025 | 229 | 9.05% | 60,859,306 | 3.40% | 105 | 1.02% | 111 | 4.72% | 67 | -6.94% |
| Jun 30, 2025 | 217 | -3.56% | 61,654,515 | 3.33% | 106 | 0.99% | 108 | -5.26% | 76 | 5.56% |
| Mar 31, 2025 | 223 | -4.29% | 59,949,912 | 0.23% | 104 | 0.95% | 113 | -12.40% | 71 | 2.90% |
| Dec 31, 2024 | 231 | 4.05% | 58,738,591 | 1.40% | 103 | 1.00% | 126 | 22.33% | 70 | 2.94% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 3.52M | 6.16% | -220.76K |
| Vanguard US Total Market Shares ETF | 1.79M | 3.12% | 2.35K |
| Vanguard Total Stock Mkt Idx Inv | 1.81M | 3.11% | -38.53K |
| Macquarie Small Cap Core I | 1.43M | 2.46% | -107.41K |
| Delaware Small Cap Core I | 1.38M | 2.42% | -8.55K |
| Vanguard Small Cap Index | 1.41M | 2.42% | -9.02K |
| iShares Russell 2000 ETF | 1.36M | 2.34% | - |
| Polar Capital Biotech S Inc | 1.00M | 1.73% | - |
| T. Rowe Price Health Sciences | 979.66K | 1.69% | -10.99K |
| DWS Vermögensbildungsfonds I LD | 805.52K | 1.39% | 3.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 05, 2026 | Milanova Tsveta | Chief Commercial Officer | Sell | $77.60K |
| Dec 30, 2025 | Burns James William | Chief Legal Officer | Sell | $79.43K |
| Dec 30, 2025 | Goff Brian | Chief Executive Officer | Sell | $337.89K |
| Dec 30, 2025 | Goff Brian | Chief Executive Officer | Sell | $168.77K |
| Dec 30, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | $79.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 1 |
| 2025 Q4 | - | 11 |
| 2025 Q3 | - | 9 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 16 |
AGIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools